Pharmaceutical supply dynamic purchasing system
Original notice title
France – Pharmaceutical products – Fourniture de spécialités pharmaceutiques dans le cadre de remise en concurrence et nouveaux besoins au profit des adhérents du GCS GRAPS Grand Est - Système d'acquisition dynamique
Opportunity Score
Why this score?
Opportunity
75 / 100
Complexity
70 / 100
Risk factors
No procurement documents beyond the XML notice were analyzed. Key details such as eligibility criteria, required docume...
Structured data and XML notice have conflicting information on EU funding (structured: true; XML: no-eu-funds). Also, s...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 1000M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 3 lots
- Duration until Nov 2031
- Supply of pharmaceutical products across 16 therapeutic categories (ATC classes A to V, plus bulk and derogatory access specialties).
- Dynamic Acquisition System (DPS) allowing periodic competitive procurement for specific needs.
Show full summary
This notice establishes a Dynamic Acquisition System (DPS) for the supply of pharmaceutical products to members of GCS GRAPS Grand Est in France. The DPS covers 16 therapeutic categories (ATC classes) and has an estimated total value of €1,000,000,000. It runs from June 2025 to November 2031. The procedure is restricted (two-stage), and electronic submission is required. No procurement documents beyond the TED XML notice were analyzed; detailed eligibility and award criteria are missing.
Risks
No procurement documents beyond the XML notice were analyzed. Key details such as eligibility criteria, required docume...
Structured data and XML notice have conflicting information on EU funding (structured: true; XML: no-eu-funds). Also, s...
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Suppliers must be capable of providing pharmaceutical products as per the defined ATC categories.
- Restricted procedure: only pre-qualified candidates may participate in subsequent tender competitions.
Administrative
- Electronic submission via the provided platform (required).
Requirements may be incomplete.
Buyer
Location
Verdun, FRA
Website
Buyer profile
Identifier
13002682600011
Activity
Health
Lots (16)
LOT-0002
A - Digestive Tract and Metabolism
Pharmaceutical products for digestive tract and metabolism disorders (ATC class A).
EUR 1B
Estimated value
Location
Duration
Category
Award details
A - VOIES DIGESTIVES ET METABOLISME
Value note
Show original TED data
Original lot title
A - VOIES DIGESTIVES ET METABOLISME
Original TED description
A - VOIES DIGESTIVES ET METABOLISME
LOT-0003
B - Blood and Blood-Forming Organs
Pharmaceutical products for blood and blood-forming organs (ATC class B).
EUR 1B
Estimated value
Location
Duration
Category
Award details
B - SANG ET ORGANES HEMATOPOIETIQUES
Value note
Show original TED data
Original lot title
B - SANG ET ORGANES HEMATOPOIETIQUES
Original TED description
B - SANG ET ORGANES HEMATOPOIETIQUES
LOT-0004
C - Cardiovascular System
Pharmaceutical products for the cardiovascular system (ATC class C).
EUR 1B
Estimated value
Location
Duration
Category
Award details
C - SYSTEME CARDIOVASCULAIRE
Value note
Show original TED data
Original lot title
C - SYSTEME CARDIOVASCULAIRE
Original TED description
C - SYSTEME CARDIOVASCULAIRE
LOT-0005
D - MEDICAMENTS DERMATOLOGIQUES
D - MEDICAMENTS DERMATOLOGIQUES
EUR 1B
Estimated value
Location
Duration
Category
Award details
D - MEDICAMENTS DERMATOLOGIQUES
LOT-0006
G - SYSTEME GENITO-URINAIRE ET HORMONES SEXUELLES
D - MEDICAMENTS DERMATOLOGIQUES
EUR 1B
Estimated value
Location
Duration
Category
Award details
D - MEDICAMENTS DERMATOLOGIQUES
LOT-0007
H - HORMONES SYSTEMIQUES
H - HORMONES SYSTEMIQUES
EUR 1B
Estimated value
Location
Duration
Category
Award details
H - HORMONES SYSTEMIQUES
LOT-0008
J - ANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
J - ANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
EUR 1B
Estimated value
Location
Duration
Category
Award details
J - ANTIINFECTIEUX GENERAUX A USAGE SYSTEMIQUE
LOT-0009
L - ANTINEOPLASIQUES ET IMMUNOMODULATEURS
L - ANTINEOPLASIQUES ET IMMUNOMODULATEURS
EUR 1B
Estimated value
Location
Duration
Category
Award details
L - ANTINEOPLASIQUES ET IMMUNOMODULATEURS
LOT-0010
M - MUSCLE ET SQUELETTE
M - MUSCLE ET SQUELETTE
EUR 1B
Estimated value
Location
Duration
Category
Award details
M - MUSCLE ET SQUELETTE
LOT-0011
N - SYSTEME NERVEUX
N - SYSTEME NERVEUX
EUR 1B
Estimated value
Location
Duration
Category
Award details
N - SYSTEME NERVEUX
LOT-0012
P - ANTIPARASITAIRES, INSECTICIDES
P - ANTIPARASITAIRES, INSECTICIDES
EUR 1B
Estimated value
Location
Duration
Category
Award details
P - ANTIPARASITAIRES, INSECTICIDES
LOT-0013
R - SYSTEME RESPIRATOIRE
R - SYSTEME RESPIRATOIRE
EUR 1B
Estimated value
Location
Duration
Category
Award details
R - SYSTEME RESPIRATOIRE
LOT-0014
S - ORGANES SENSORIELS
S - ORGANES SENSORIELS
EUR 1B
Estimated value
Location
Duration
Category
Award details
S - ORGANES SENSORIELS
LOT-0015
V - DIVERS
S - ORGANES SENSORIELS
EUR 1B
Estimated value
Location
Duration
Category
Award details
S - ORGANES SENSORIELS
LOT-0016
PRESENTATIONS VRAC (toutes classes ATC confondues)
PRESENTATIONS VRAC (toutes classes ATC confondues)
EUR 1B
Estimated value
Location
Duration
Category
Award details
PRESENTATIONS VRAC (toutes classes ATC confondues)
LOT-0017
SPECIALITES EN ACCES DEROGATOIRE (AAC, AP...)
SPECIALITES EN ACCES DEROGATOIRE (AAC, AP...)
EUR 1B
Estimated value
Location
Duration
Category
Award details
SPECIALITES EN ACCES DEROGATOIRE (AAC, AP...)
Procurement Details
- Publication date
- 19 May 2025
- Languages
- French
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 324751-2025
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
75 / 100
Complexity
70 / 100
Risk factors
No procurement documents beyond the XML notice were analyzed. Key details such as eligibility criteria, required docume...
Structured data and XML notice have conflicting information on EU funding (structured: true; XML: no-eu-funds). Also, s...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications